Is it all too Weird?
- May 11, 2022
- 1 min read
With the finale of Moon Knight and the release of Dr. Strange in the Multiverse of Madness, the combined weirdness of those two MCU releases has me wondering – has the MCU gone too far to the weird side?
After Endgame, the slew of MCU properties released has definitely titled towards the odd (Wandavision, Loki, and even Shang-Chi and Spiderman No Way Home were in that camp). Moon Knight and Dr. Strange in the Multiverse of Madness took that weird and doubled down on it. Not to say that these properties aren’t good (as most of them are and some are even exceptional) but I wonder how far will this go? Is it all heading in that direction?
This alse had me thinking of other weird series and films I’ve seen recently outside the MCU, like The Unbearable Weight of Massive Talent, The Northman, Severance, Russian Doll, Peacemaker, Yellowjackets, Succession and Outer Range, and asking a much broader question: has it all gotten just too strange? If the answer is yes, then why? Is it the strangeness of the world we live in now? Has technology made us a much weirder species?
It almost seems like odd and weird is becoming the norm and that it will feel refreshingly new to watch something that is by-the-book but of high quality (much like CODA was).
Whether this is a good or bad wave is hard to say, but it is original and you can’t say you’re bored!
Understanding GLP-1 Medications: Mechanisms, Benefits, and Role in Weight Management and Type 2 Diabetes
What Are GLP-1 Medications?
GLP-1, or glucagon-like peptide-1, is a natural hormone produced in the gut that plays a crucial role in regulating blood sugar levels and appetite. GLP-1 medications, also known as GLP-1 receptor agonists, are synthetic versions of this hormone designed to mimic its effects in the body. These medications have revolutionized the treatment of type 2 diabetes and obesity by offering a dual-action approach that not only improves blood sugar control but also promotes significant weight loss. As peptide therapy advances, GLP-1 receptor agonists have become a cornerstone in modern metabolic health management, offering hope to millions struggling with these chronic conditions.
The…